|
|||||
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions 
New data from a continuing survey of smoking among school-age children shows large increases in electronic cigarette use in high school and middle school children in just the past year. . . . → Read More: Survey Shows Sharp Rise in Teen E-Cigarette Use 
The Food and Drug Administration says it’s streamlining policies for making drugs and medical devices in clinical trials or under review available for people in the U.S. with life-threatening conditions. . . . → Read More: FDA Updating Expanded Access to Investigational Drugs, Devices 
The Food and Drug Administration cleared a consumer genetics company’s tests for gene variations associated with effective or adverse drug reactions, but warned about similar tests from non-authorized providers. . . . → Read More: FDA Clears Some Drug Reaction Genetic Tests, Warns About Others  One comment - (Comments are closed)  New products, Regulations  biomedical, engineering, FDA, genomics, life sciences, medical device, pharmaceuticals 
The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants. . . . → Read More: FDA Preparing Animal, Plant Biotech Regulatory Guidance 2 comments - (Comments are closed) Regulations agriculture, biotechnology, FDA, genomics, life sciences, pharmaceuticals 
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years. . . . → Read More: Diabetes Drug Assessed Long-Term Against All Other Treatments Comments are closed Regulations biomedical, clinical trials, FDA, life sciences, pharmaceuticals, university 
(Marco Verch, Flickr) 1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual . . . → Read More: FDA Clears Genomic Bone Marrow Test for Low-Level Cancer One comment - (Comments are closed) Regulations biomedical, cancer, clinical trials, engineering, FDA, genomics, life sciences, medical device 
A test that inspects a patient’s blood sample for characteristic indicators of solid-tumor cancer, and can be part of a comprehensive precision analytics program, is now on the market. . . . → Read More: Liquid Biopsy for Solid Tumors Now Available One comment - (Comments are closed) New products biomedical, cancer, engineering, Europe, FDA, genomics, life sciences, mathematics, medical device, software 
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs One comment - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, cancer, clinical trials, FDA, genomics, life sciences, mathematics, pharmaceuticals, special, university 
An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year. . . . → Read More: Clinical Trial Underway for Lassa Fever Treatment Comments are closed New products Africa, biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
